Primary Ovarian Insufficiency

On this page

Primary Ovarian Insufficiency - Ovarian Fade-Out

  • Depletion/dysfunction of ovarian follicles < 40 yrs. Leads to amenorrhea (≥4 months), hypoestrogenism, & persistently ↑FSH (>25-40 IU/L, measured twice >4 wks apart).
  • Etiology:
    • Idiopathic (most common)
    • Genetic: Turner syndrome (45,X0), Fragile X premutation (FMR1)
    • Autoimmune disorders (e.g., autoimmune oophoritis, thyroiditis)
    • Iatrogenic: Chemotherapy, radiotherapy, ovarian surgery
    • Environmental toxins, infections (mumps), galactosemia
  • Key Concerns: Infertility, osteoporosis, cardiovascular risks, psychological impact.
  • Management: HRT (estrogen + progestin until avg. age of menopause), calcium/Vit D. Fertility via oocyte donation. Ovarian Follicle Depletion in Primary Ovarian Insufficiency

⭐ Most common genetic causes of POI include Turner Syndrome (45,X0) and FMR1 gene premutation (Fragile X).

Primary Ovarian Insufficiency - Clues & Confirmation

  • Clinical Clues:
    • Age < 40 years
    • Menstrual dysfunction: Amenorrhea (secondary > primary) or oligomenorrhea (≥ 4 months)
    • Hypoestrogenic symptoms:
      • Vasomotor: Hot flushes, night sweats
      • Urogenital: Vaginal dryness, dyspareunia
      • Psychological: Mood swings, sleep disturbance
    • Infertility
  • Diagnostic Confirmation:
    • Biochemical (key):
      • ↑ Serum FSH > 25-40 IU/L (on 2 occasions, >4 weeks apart)
      • ↓ Serum Estradiol < 50 pg/mL
    • Etiological workup:
      • Karyotype: Rule out Turner (45,X), Y chromosome presence
      • FMR1 gene testing: For Fragile X premutation (esp. if family hx)
      • Autoimmune screening: TSH, anti-TPO Ab; consider anti-adrenal Ab
      • Ovarian reserve markers: ↓AMH, ↓Antral Follicle Count (AFC) on ultrasound

⭐ Karyotyping is crucial in all women with POI diagnosed before age 30 to detect Turner syndrome mosaics or Y chromosome material, which carries a risk of gonadoblastoma.

Primary Ovarian Insufficiency - Hormone Harmony & Hope

  • Hormone Replacement Therapy (HRT): Mainstay treatment.
    • Aims: Symptom relief (vasomotor, urogenital), bone protection, improved well-being.
    • Regimen (with uterus): Estrogen + Progestin.
      • Estrogen: e.g., Estradiol 1-2 mg/day (oral), 50-100 µg/day (transdermal).
      • Progestin: e.g., MPA 5-10 mg/day or micronized progesterone 200 mg/day, for 12-14 days/month.
    • Duration: Until median age of natural menopause (~51 years).
  • Fertility Management:
    • Spontaneous pregnancy: Rare (5-10%).
    • Oocyte donation: Best success.
    • Adoption.
  • Bone Health:
    • Calcium 1200 mg/day, Vitamin D 800-1000 IU/day.
    • Weight-bearing exercise. DEXA scan.
  • Psychosocial Support: Essential.
    • Counseling, support groups.

⭐ HRT in POI should continue until the average age of natural menopause (~51 years) to mitigate long-term risks like osteoporosis and cardiovascular issues.

Primary Ovarian Insufficiency - Ripple Effects

  • Infertility: Primary and often devastating consequence.
  • Bone Health: ↓ Estrogen leads to ↑ bone resorption, significantly ↑ osteoporosis risk.
    • Regular DEXA screening recommended.
  • Cardiovascular Disease (CVD): Premature estrogen loss ↑ risk of heart disease.
    • Monitor lipids, BP.
  • Psychological & Sexual: Mood disorders (depression, anxiety); vaginal atrophy, dyspareunia, ↓ libido.
  • Associated Autoimmune Disorders: Higher incidence of thyroiditis, Addison's.
  • Management Focus: HRT until natural menopause age (~51 yrs) to mitigate risks.

⭐ Untreated POI significantly increases risk of premature mortality, mainly from cardiovascular events and osteoporotic fractures.

POI: Follicle Development, Atresia, and Health Effects

High‑Yield Points - ⚡ Biggest Takeaways

  • Primary Ovarian Insufficiency (POI): Ovarian failure before age 40, with amenorrhea and menopausal symptoms.
  • Hormonal hallmarks: ↑FSH (>25-40 IU/L, repeat), ↑LH, ↓estradiol, ↓AMH.
  • Common causes: Idiopathic (often autoimmune); genetic (e.g., Turner syndrome, Fragile X premutation).
  • Essential workup: Karyotyping in women with POI diagnosed < age 30.
  • Major complications: Osteoporosis, cardiovascular disease, infertility, psychological distress.
  • Management: HRT until natural menopause age (~51 years); oocyte donation for fertility_._

Practice Questions: Primary Ovarian Insufficiency

Test your understanding with these related questions

Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?

1 of 5

Flashcards: Primary Ovarian Insufficiency

1/10

_____ disorder of sex development (DSD) is characterized by the presence of both ovarian and testicular tissue in the same individual

TAP TO REVEAL ANSWER

_____ disorder of sex development (DSD) is characterized by the presence of both ovarian and testicular tissue in the same individual

Ovotesticular

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial